Alder BioPharmaceuticals® appoints Jeremy Green to its board of directors
Alder Biopharmaceuticals announced that its Board of Directors has unanimously appointed Jeremy Green, Founder and Portfolio Manager of Redmile Group, to the Company’s Board. Mr. Green will serve as a Class III director with a term expiring at the Company’s 2020 Annual Meeting. April 26, 2018